Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
To establish the safety and efficacy of two dose levels of ex-vivo cultured adult human mesenchymal stem cells (hMSCs) (Prochymal®) in participants experiencing acute GVHD, Grades II-IV, post hematopoietic stem cells (HSC) transplant.
Epistemonikos ID: 89b1eacf9d575660cd0e7e673f8de160e7eec81c
First added on: May 04, 2024